Clinical Trial

NH002-mediated Sonoporation With Chemotherapy in Advanced Pancreatic Cancer

Name: NH002-mediated Sonoporation With Chemotherapy in Advanced Pancreatic Cancer — clinical trial record (NCT07314385)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 1

View on ClinicalTrials.gov →

Summary

This is a phase I study that will enroll patients with pancreatic cancer and liver metastasis who have failed prior gemcitabine-based chemotherapy. Patients will be treated with nanoliposomal irinotecan plus 5-FU and leucovorin and NH002-based sonoporation to the liver metastasis.

Trial Details

NCT Number	NCT07314385
Lead Sponsor	National Taiwan University Hospital Collaborators: Trust Bio-sonics, Inc.
Conditions	Pancreatic Adenocarcinoma Metastatic, Liver Metastasis
Enrollment	24 participants
Start Date	2026-01-01
Primary Completion	2027-12-31 (estimated)
Study Completion	2027-12-31 (estimated)
Updated on ClinicalTrials.gov	2026-01-02